Screening for Hemochromatosis: High Prevalence and Low Morbidity in an Unselected Population of 65,238 Persons

Powell LW, 2000, Haemochromatosis in the new millennium. J Hepatol, 32, 48

10.1056/NEJM199306033282208

Haddow JE, 1994, J Med Screen, 1, 16, 10.1177/096914139400100106

Feder JN, 1996, Nat Genet, 13, 399, 10.1038/ng0896-399

Merryweather Clarke AT, 1997, J Med Genet, 34, 275, 10.1136/jmg.34.4.275

Bacon BR, 1999, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology, 116, 193

Niederau C, 1994, Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv Exp Med Biol, 356, 293

Niederau C, 1994, Clinical spectrum and management of haemochromatosis. Baillieres Clin Haematol, 7, 881, 10.1016/S0950-3536(05)80129-5

Niederau C, 1996, Gastroenterology, 110, 1107, 10.1053/gast.1996.v110.pm8613000

Witte DL, 1996, Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta, 245, 139

Burke W, 1998, JAMA, 280, 172, 10.1001/jama.280.2.172

Buffone GJ, 1994, Clin Chem, 40, 1631, 10.1093/clinchem/40.8.1631

Phatak PD, 1994, Cost- effectiveness of screening for hereditary hemochromatosis. Arch Intern Med, 154, 769

10.1016/0016-5085(95)90283-X

Karlsson M, 1988, Acta Med Scand, 224, 385, 10.1111/j.0954-6820.1988.tb19599.x

Wiggers P, 1991, Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med, 230, 265

Bell H, 1997, J Hepatol, 26, 272, 10.1016/S0168-8278(97)80041-4

Adams PC, 2000, Hepatology, 31, 1160, 10.1053/he.2000.6984

Balan V, 1994, Gastroenterology, 107, 453, 10.1016/0016-5085(94)90171-6

Hallberg L, 1989, J Intern Med, 225, 249, 10.1111/j.1365-2796.1989.tb00074.x

Hickman PE, 2000, Gut, 46, 405, 10.1136/gut.46.3.405

Siedel J, 1984, AACC meeting abstract. Clin Chem, 30, 975

Jeffrey GP, 1999, Nat Genet, 22, 325, 10.1038/11892

Kalbfleisch JD, 1980, New York:Wiley, p. 10

Adams P, 2000, EASL International Consensus Conference on Haemochromatosis. J Hepatol, 33, 485

Bassett ML, 1986, Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology, 6, 24

Niederau C, 1998, Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med, 128, 337

McDonnell SM, 1999, Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med, 107, 30

Mueller RF, 1998, Edinburgh: Churchill Livingstone, p. 113

10.1056/NEJM199909023411002

Bell H, 2000, Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects. Scand J Gastroenterol, 35, 1301

Cardoso EM, 1998, HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med, 243, 203

Cogswell ME, 1998, Ann Intern Med, 129, 971, 10.7326/0003-4819-129-11_Part_2-199812011-00008

Adams PC, 1997, Hepatology, 25, 162, 10.1002/hep.510250130